FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081009165> ?p ?o ?g. }

• W2081009165 endingPage "578" @default.
• W2081009165 startingPage "553" @default.
• W2081009165 abstract "We have extended the algebraic models for cancer initiation and progression developed by Nordling, Armitage-Doll and Knudson-Moolgavkar to include the effect of cell turnover rate in normal tissue, stochastic growth of preneoplastic adenomas, and the general case wherein a subfraction of the population is at risk. We have also gathered the mortality data available for the United States from 1900 to 1991 and categorically organized them by birth year cohorts and age specific death rates for ages 0 to 104 in 5-year groupings. Using these data, we first explored the quantitative nature of the biases of underreporting or misdiagnosis as historical age-dependent functions. Then we used the extended algebraic model to calculate the parameters of subpopulation fraction at risk, mutation rates and adenoma growth rates. We observe that death rates for all cancers are low in childhood and early adulthood, rise in middle age in approximately linear manner, reach a maximum in old age, and even after correction for reporting bias, decrease markedly in extreme old age. We represent this behavior as the natural result of a continuous process of cell division, death and mutation within a subpopulation at risk. This population at risk within any birth cohort is defined by the product of a constant inherited risk factor multiplied by a historically valuable environmental risk factor. Our formulation permits explicit calculation of the fraction at risk of death from any cancer as a historical function. With regard to the algebraic description of the process of carcinogenesis, we use Nordling's concept that n genetic events in a cell population of constant cell number are required to initiate a colony capable of net cell growth or ‘adenoma’. We adopt and extend Moolgavkar's use of the ‘Gambler's Ruin’ stochastic process to describe the probability of adenoma survival and the canonical expectation that a surviving adenoma will soon contain many initiated cells by virtue of stochastic distribution of surviving cells. We consider that within the growing adenoma, it is necessary for a cell to acquire m additional mutations in order to attain the carcinoma phenotype of cell growth rapid enough to kill in a short time. This would be irrespective of the need for any additional genetic events that may define the subsequent phenotypes of large lethal tumors, as these would be automatically acquired and be physiologically selected in any rapidly growing cell mass. It is evident that the steps of initiation and progression are dependent on both the rates of genetic change per cell division and the cell kinetic rates of division and death. We have chosen to first examine colon cancer because the rates of cell division in normal colonic epithelium, dysplastic adenomas and small carcinomas have been directly observed as reported herein. For colon cancer, we calculate that about 65% of the US population is at risk for both males and females, and that this fraction has been constant for the earliest recorded birth cohorts of the mid-19th century to the beginning of the 20th century. The changes that have been observed in colon cancer mortality rates appear to arise from historical changes in death rates by unknown ‘other causes of death’, which share both genetic and environmental risk factors with colon cancer and explicitly include undiagnosed deaths by colon cancer. Considering all possible values of n and m, we find the case of n = 2 and m = 1 to give the best concordance with present knowledge of mutations in the colon by the loss of two alleles of the APC gene and the observation that for m = 1, a rate of genetic change approximately equal to that calculated for initiation mutation rates is obtained. Our estimates for the rate of initiation and progression mutation rates show no significant historical shifts and are approximately 1−2x10−7 events per cell division. This value is close to the observed spontaneous rate of mutation of human cells in culture for allelic knockout and the observed annual rate of hprt and HLA losses in human peripheral T cells. In particular, there is no indication of a requirement for genomic instability in these first three rate-limiting steps for the case n = 2 and m = 1." @default.
• W2081009165 created "2016-06-24" @default.
• W2081009165 creator A5006688526 @default.
• W2081009165 creator A5031733622 @default.
• W2081009165 creator A5041567278 @default.
• W2081009165 creator A5042763431 @default.
• W2081009165 creator A5049356247 @default.
• W2081009165 creator A5067660983 @default.
• W2081009165 creator A5058709286 @default.
• W2081009165 date "1998-05-01" @default.
• W2081009165 modified "2023-10-17" @default.
• W2081009165 title "Mutation, cell kinetics, and subpopulations at risk for colon cancer in the United States" @default.
• W2081009165 cites W1893676831 @default.
• W2081009165 cites W1908327267 @default.
• W2081009165 cites W1913147314 @default.
• W2081009165 cites W1972357604 @default.
• W2081009165 cites W1985091316 @default.
• W2081009165 cites W1987787926 @default.
• W2081009165 cites W2013743651 @default.
• W2081009165 cites W2018348035 @default.
• W2081009165 cites W2019349530 @default.
• W2081009165 cites W2033344778 @default.
• W2081009165 cites W2040770189 @default.
• W2081009165 cites W2041106214 @default.
• W2081009165 cites W2045582876 @default.
• W2081009165 cites W2051621914 @default.
• W2081009165 cites W2055882979 @default.
• W2081009165 cites W2058687572 @default.
• W2081009165 cites W2072928176 @default.
• W2081009165 cites W2077876866 @default.
• W2081009165 cites W2082470200 @default.
• W2081009165 cites W2084743950 @default.
• W2081009165 cites W2093531978 @default.
• W2081009165 cites W2095550112 @default.
• W2081009165 cites W2147631978 @default.
• W2081009165 cites W2341209396 @default.
• W2081009165 cites W4248142848 @default.
• W2081009165 doi "https://doi.org/10.1016/s0027-5107(98)00067-0" @default.
• W2081009165 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9685710" @default.
• W2081009165 hasPublicationYear "1998" @default.
• W2081009165 type Work @default.
• W2081009165 sameAs 2081009165 @default.
• W2081009165 citedByCount "52" @default.
• W2081009165 countsByYear W20810091652013 @default.
• W2081009165 countsByYear W20810091652014 @default.
• W2081009165 countsByYear W20810091652016 @default.
• W2081009165 crossrefType "journal-article" @default.
• W2081009165 hasAuthorship W2081009165A5006688526 @default.
• W2081009165 hasAuthorship W2081009165A5031733622 @default.
• W2081009165 hasAuthorship W2081009165A5041567278 @default.
• W2081009165 hasAuthorship W2081009165A5042763431 @default.
• W2081009165 hasAuthorship W2081009165A5049356247 @default.
• W2081009165 hasAuthorship W2081009165A5058709286 @default.
• W2081009165 hasAuthorship W2081009165A5067660983 @default.
• W2081009165 hasBestOaLocation W20810091651 @default.
• W2081009165 hasConcept C104317684 @default.
• W2081009165 hasConcept C121608353 @default.
• W2081009165 hasConcept C126322002 @default.
• W2081009165 hasConcept C143998085 @default.
• W2081009165 hasConcept C144024400 @default.
• W2081009165 hasConcept C149923435 @default.
• W2081009165 hasConcept C179755657 @default.
• W2081009165 hasConcept C2908647359 @default.
• W2081009165 hasConcept C501734568 @default.
• W2081009165 hasConcept C50440223 @default.
• W2081009165 hasConcept C54355233 @default.
• W2081009165 hasConcept C555283112 @default.
• W2081009165 hasConcept C65990518 @default.
• W2081009165 hasConcept C71924100 @default.
• W2081009165 hasConcept C86803240 @default.
• W2081009165 hasConcept C98638677 @default.
• W2081009165 hasConceptScore W2081009165C104317684 @default.
• W2081009165 hasConceptScore W2081009165C121608353 @default.
• W2081009165 hasConceptScore W2081009165C126322002 @default.
• W2081009165 hasConceptScore W2081009165C143998085 @default.
• W2081009165 hasConceptScore W2081009165C144024400 @default.
• W2081009165 hasConceptScore W2081009165C149923435 @default.
• W2081009165 hasConceptScore W2081009165C179755657 @default.
• W2081009165 hasConceptScore W2081009165C2908647359 @default.
• W2081009165 hasConceptScore W2081009165C501734568 @default.
• W2081009165 hasConceptScore W2081009165C50440223 @default.
• W2081009165 hasConceptScore W2081009165C54355233 @default.
• W2081009165 hasConceptScore W2081009165C555283112 @default.
• W2081009165 hasConceptScore W2081009165C65990518 @default.
• W2081009165 hasConceptScore W2081009165C71924100 @default.
• W2081009165 hasConceptScore W2081009165C86803240 @default.
• W2081009165 hasConceptScore W2081009165C98638677 @default.
• W2081009165 hasIssue "1-2" @default.
• W2081009165 hasLocation W20810091651 @default.
• W2081009165 hasLocation W20810091652 @default.
• W2081009165 hasOpenAccess W2081009165 @default.
• W2081009165 hasPrimaryLocation W20810091651 @default.
• W2081009165 hasRelatedWork W1967821671 @default.
• W2081009165 hasRelatedWork W1969795570 @default.
• W2081009165 hasRelatedWork W2024289194 @default.
• W2081009165 hasRelatedWork W2063657731 @default.
• W2081009165 hasRelatedWork W2063781606 @default.
• W2081009165 hasRelatedWork W2125789691 @default.

• next